Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Mississippi Department Of Health Prepares For Potential Hurricane Season Evacuations With The AmbuBus
With the 2009 hurricane season underway, Mississippi has joined other states in FEMA Region IV by deploying the AmbuBus from First Line Technology in a statewide effort to enhance special needs evacuation capabilities. Delivery of the initial 14 AmbuBus kits, purchased through grant funds, were delivered to 6 different locations around the state. A joint training session was conducted between the school districts and the Department of Health to prepare for summertime severe weather.
generic viagra online
ZyGEM Releases Data Confirming Its PrepGEM(R) Bacteria Kit Is A Simple, Universal Method For Extracting DNA From Different Bacteria Species
ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced the availability of a new application note documenting that its prepGEM(R) Bacteria DNA extraction kit is capable of producing high quality, ready-to-analyze DNA from a broad range of bacterial species, including mixed or unknown sample types. This addresses an important unmet need --current DNA extraction methods typically require the use of different enzymes for each type of bacteria tested. The prepGEM(R) Bacteria kit also uses a single closed-tube system that reduces extraction time and cost while protecting the sample from contamination and making the kit easily adaptable for automation.
News of the day
Initial Therapy With Janumet™ Provided Significantly Greater Blood Sugar Lowering Compared To Metformin Alone In Type 2 Diabetes
New data presented at the American Diabetes Association (ADA) 69th Annual Scientific Sessions showed that initial treatment with "Janumet"* (sitagliptin/metformin) provided significantly greater blood sugar improvements in drug-naç¯ve** patients with type 2 diabetes, compared with metformin alone.[i]
Medical Devices

Radiant Research, Inc. Prepares For Upcoming H1N1 Vaccine Trials

Radiant Research, Inc. announced that it is actively recruiting subjects and establishing operational plans for upcoming H1N1 vaccine trials. The World Health Organization declared the H1N1 influenza outbreak a pandemic, and the CDC has shipped virus samples to several manufacturers with the hope of having vaccine available to the general public by the fall. Manufacturers will need to complete clinical trials prior to release of vaccine to the public. "Our research sites are ideal for this type of clinical trial," said Julie McHugh, Vice President of Late Phase Clinical Research, Radiant Research, Inc. "We have conducted over 200 vaccine trials and enrolled thousands of subjects into these trials in the past five years. We know how to enroll these trials quickly and efficiently, and we enforce the standards that ensure quality data collection." "We have over a million subjects in our database and they are both familiar with the research process and very interested in this type of trial," said Michael Kritschgau, Vice President of Radiant Recruitment. "We are currently making contact with these potential subjects so we can be ready to enroll once the manufacturers are ready to move to the clinical trials stage. We anticipate that companies producing the vaccine will soon be reaching out to various research. Radiant Research, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009